Lataa...
Assays and technologies for developing proteolysis targeting chimera degraders
Targeted protein degradation by small-molecule degraders represents an emerging mode of action in drug discovery. Proteolysis targeting chimeras (PROTACs) are small molecules that can recruit an E3 ligase and a protein of interest (POI) into proximity, leading to induced ubiquitination and degradati...
Tallennettuna:
| Julkaisussa: | Future Med Chem |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Newlands Press Ltd
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7333641/ https://ncbi.nlm.nih.gov/pubmed/32431173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc-2020-0073 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|